Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes (Q38323148)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes |
scientific article |
Statements
1 reference
Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes (English)
1 reference
Victor A Gault
1 reference
Nigel Irwin
1 reference
Brian D Green
1 reference
Jane T McCluskey
1 reference
Brett Greer
1 reference
Clifford J Bailey
1 reference
Patrick Harriott
1 reference
Finbarr P M O'harte
1 reference
Peter R Flatt
1 reference
1 August 2005
1 reference
Identifiers
1 reference